Legal considerations that affect medical eligibility for competetive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations  by Mitten, Matthew J. & Maron, Barry J.
Several rccclH high visibility CLISCS. ~ilrtiCl~li~r~y thC tragic 
deaths of Rcggic Lewis and ank Gatbcrs, have raised certain 
issues in tllc public consciousness with IYgikld to thC CilK,!iO- 
VXiCUh~ CiILISCS Of SU&lCll CWdiilC ClCill~l in highly trained 
ilthlCtCS ( 1-3) illld. in pilrtiCUlil~, the pWCCSSCS fW dctcrniining 
eligibility for sports in such circurnstanccs. Guidance for 
physicians is now available in tbc recommendations set forth in 
this consensus report, a revision of the I985 10th Bethesda 
Conference, also published in the .loutwtl uj’ f/w Attwicm 
Collqp oj’ Cm-diology (4). 
Various psychologic and economic factors, coupled with the 
great importance and visibility that competitive sports have 
achieved in this country, have resulted in several recent 
lawsuits challenging physicians’ medical evaluation of athlctcs 
with cardiovascular abnormalities and their recommendations 
for participation (S-8). The developing legal framework for 
resolving disputes with regard to assessing eligibility of athletes 
with a cardiovascular abnormality will bc greatly infucnced by 
the medical judgment of cardiologists and other physicians. 
In the course of this discussion wc cndcavor to intcgratc 
perspectives of the medical and legal professions, in the hope 
that such a focus may clarify the physician’s role in assessing 
the eligibility of athletes with cardiovascular abnormalities for 
participation in competitive sports, and also prevent future 
tragedies on the athletic field. 
Protecting the athlete’s health and physical well-being 
should be the physician’s paramount concern regardless of any 
extrinsic or nonmedical considerations that may affect that 
particular situation (9,lO). The principal difficulty encountered 
by physicians in making eligibility recommendations for com- 
petitive athletes appears to arise from the potentially antago- 
nistic positions taken by other concerned parties, such as the 
school (or professional team), the athlete or the family, whose 
primary objective may be to have the athlete continue in the 
competitive arena. Within the physician-athlete relationship 
may also reside the dilemma of the physician’s “divided (dual) 
loyalty” between the welfare of the athlete and needs of the 
team and also between the welfare and the desires of the 
athlete ( I I ,12). These conflicting objectives may become c en 
more acute when the physician is compensated for his scrvi<es 
by the Wlill or organization, 
Tllc uiltletek primary concern is usually a strong desire to 
continue playing, in the pursuit of psychologic or linancial 
rewards, CVCII with the knowlcdgc that potentially Icthal car- 
diovascular disease is present. Young athletes, in particular, 
often feel invincible, free of the risks of normal living and 
desire to remain in competitive sports regardless of the health 
risks (13). 
The schooled (high school or college/university) or ~~~~~fi.~- 
siotxtl tmtt ‘s interest is to establish appropriate physical qual- 
itications to protect the health and safety of their athletes (13). 
Potentially antagonistic to this objective arc the aspilations of 
the educational institution or professional team to develop 
successful, highly visible and financially profitable athletic 
programs, and the needs of the team to attract and maintain 
elite athlctcs. 
Athletic governing bodies at the high school, college and 
professional levels currently do not have established rules or 
regulations governing exclusion of an athlete with a cdrdiovas- 
cular abnormality from participation in competitive sports. At 
present, most athletic teams generally accept the designated 
team physician’s medical recommendation with regard to the 
fitness of an athlete to play a sport (13). 
Ideally, the ultimate decision whether to participate in a sport 
with a cardiovascular abnormality should bc the product of 
mutual agreement bctwecn the team physician, consulting cardi- 
ologists, team officials, the athlete and his or her family. Certainly, 
the more elite the athlete, the more complex and ditlicult is the 
resolution of eligibility decisions, particularly in borderline cases. 
Indeed, despite recent tragedies on the athletic field, scvcra~ 
athletes with hypertrophic cardiomyopathy or other potentially 
lethal cardiovascular abnormalities are currently Competing ill 
college or professional athletics with medical clearance (14-17). 
Some have signed waivers releasing their institutions from liability 
if they are injured or die as a result of their medical condition 
01994 hy the American College of Cardiolo&y and American College of Sporls Medicine 
862 MIlTEN AND MARON 
LEGAL CONSIDERATIONS 
JACC Vol. 24, No. 4 
October 1994:x45-99 
during athletic competition (14,15), but the legal enforceability of 
such waivers is judiciahy unresolved at present. 
Legal 
Disagreements with regard to the propriety of competitive 
athletic participation with a cardiovascular abnormality may be 
resolved on an in&idual basis under the Americans with 
Disabilities Act of 1990 (ADA), the Rehabilitation Act of 1973 
or similar state statutes prohibiting unjustilied discrimination 
against physically impaired athletes (13,18,19). These statutes 
provide that an athlete with the physical capabilities and skills 
necessrtry to play a sport despite a cardiovascular abnormality 
is entitled to have his or her condition individually evaluated in 
light of medical evidence, Exclusion from an athletic team 
must be based on reasonable medical judgments, given the 
state of scientihc knowledge. Thcsc statutes also reyuirc 
careful balancing of an impaired athlete’s right to participate in 
athletic activities within his or her physical ahilities, physician 
evaluation of the medical risks of athletic participation and the 
team’s interests in conducting a safe athletic program (13). 
In attempting to resolve disputes regarding whether an 
athlete with a cardiovascular ahnormality should be permitted 
to play a competitive sport, courts rely heavily on medical 
testimony documenting the risks of athletic participation under 
such circumstances. In Larkin v Amhdiocese of Cincinrrari (5). 
the trial court held that a high school could exclude one of its 
students, Stephen Larkin, from its football team because he 
had structural heart disease. The court based its decision on 
the unanimous rccommcndations of examining cardiologists 
against Larkin’s continued participation in competitive, intcr- 
scholastic sports and held that such exclusion did not violatc 
the Rehabilitation Act of 1973. The family (on behalf of their 
son, a Icgal minor) was informed of the medical risks of his 
athletic participation and were willing to waive any future 
claims against the school if he were permitted to play foothall. 
The court concluded that Stephen Larkin did not satisfy a 
justitiable Ohio High School Athletic Association bylaw re- 
quiring a physician’s certification of his fitness and that his 
parents did not have the legal capacity to waive their minor 
son’s righ!s. 
In the well publicized case of former Boston Celtics’ 
basketball player Reggie Lewis (3) (which has not involved 
litigation), medical experts were sharply divergent with regard 
to their diagnosis and evaluation of the risks associated with 
Lewis’ continued athletic participation. Lewis died during a 
medically unsupervised workout. and an autopsy showed his 
heart to be abnormal. with ventriculur cavity enlargement and 
extensive scarring, findings consistent with healed myocarditis. 
As yet, no court has considered the question of whether an 
athIete with a cardiovascular abnormality may be involuntarily 
excluded from a sport if medical experts disagree in their 
participation recommendations. An athlete who has been 
denied medical clearance to play a sport may seek opinions 
from other physicians to convince team olficials or a court that 
he or she is medica@ fit to play. In resolving such a dispute, a 
court probably would consider whether there is a relatively 
equal split of medical opinion regarding an athletic clearance 
recommendation in a bordenline case, or whether a single 
physician’s opinion deviates from either accepted or customary 
medical practice. Indeed, consensus recommendations in this 
Bethesda Conference report may potentially assist courts and 
lay athletic officials in evaluating the merits of conflicting 
participation recommendations. 
There arc few reported cases discussing the appropriate 
legal standard of care for evaluating and diagnosing an ath- 
lete’s physical condition and making medical clearance recom- 
mendations. The law enables the medical professiom to estabb- 
lish the bounds of appropriate physician maflageme~t of 
athletes; indeed, it is the ~?e~~ica~ standard that is ultimately 
translated into the legal standard for malpractice purposes 
(O,!(l). Traditionally, in nlalpracticc claims the applicable legal 
standard of medical care within the physician’s pecialty (i.c., 
“good medical practice”) is defined judicially as cithcr the 
customary or acccptcd cart under the circumstances (9,10). In 
treating athletes with cardiovascu!ar conditions, physicians are 
liable for malpractice only if they deviate from p*ofcssionally 
determined standards; that is, by failing to conduct appropriate 
diagnostic tests, incomplete disclosure of the medical risks of 
competitive athletic participation, improperly clearing an ath- 
letc to play with a cardiovascular a~n[~rmali~ or failing to 
follow guidelines accepted by the medical profession as the 
standard of cart. 
Perhaps the most publisizcd malpractice lawsutt thus far 
involving the medical care of a competitive athlete concerned 
Hank Gathers (I), a nationally recognized basketball player at 
Loyola-Marymount University in Los Angeles who collapsed 
and died on the basketball court during an intercollegiate 
game in March 1990. In Gcrtltcrs I’Loyola-Matymounr Univerdy 
(6). the Gathers heirs alleged that Gathers was not fully 
informed of the seriousness of his heart condition, should not 
have been medically cleared to continue playing college bas- 
ketball, and was given a nontherapeutic dosage of heart 
medication to enable him to perform. The Gathers case raised, 
but did not resolve, a number of important medical and legal 
issues concerning the appropriate care of an athlete with a 
known cardiovascular abnormality and a competitive athlete’s 
responsibility to protect his or her health. 
A pending lawsuit broug,,: by the mother of former Oregon 
State University basketball player Earnest Killum, Lillard v 
Sme of Oregorl (7) alleges that he was improperly cleared to 
resume playing basketball, which led to his death. This case is 
similar to the Gathers suit in that both alleged malpractice by 
the treating physicians and interference with an athlete’s 
medical cart by athletic officials, Killum had a history of two 
strokes and then experienced numbness and slurred speech 
during a basketball game; tests determined that he had periph- 
eral vascular disease. Physicians prescribed anticoagulant 
agents, and he was initially advised to withdraw from compet- 
itive basketball. Thereafter, medications were reduced, and 
Killum was cleared to resume college basketball despite rec- 
ommendations to the contrary by a consultant. He died 1 
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month later, appareut~y of a massive cereb edical practice establishes a benchmark 
for legal standards, so, too, may 
me a useful resource 
gibility disputes when 
tinued participation in college basketball. Two other cardiolo- 
gists concurred with this opinion, and Central Connecticut 
State University refused to allow nny to engage in its 
tball program for two seasons. Penny ultimately obtained 
al clearance for competitive sports from two other 
~estjmouy with respect to the propriety ofathletic ~a~~c~pat~on 
with a cardiovascular abnormality. Should litigation arise ani; 
these recommendations ultimately relied on as the legal stan- 
dard of care, physicia would be prospectively informed as to 
the expectations of e law, self-regulation would be sup- 
ported, and eligibility decisions made by individual physicians 
consistent with the recommendations should be insulated from 
malpractice liability. In these respects, it would clearly be in the 
best interests of physicians charged with responsibility for
making eligibility decisions concerning athletes tohave xisting 
and systematic recommendations on which to rely. 
intercollegiate basketball. Penny 
death, and therefore the court did not consider the claim, it 
appears unlikely that pliysic~au rec~n~~~le us a~~~~~s~ en- 
gaging in a competitive sport with a rly diagnosed 
cardiovascular abnormality would be recognized judicially. 
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